For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...

Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and ...

About 1 in 10 adults aged 70 or older may be eligible for anti-amyloid therapy, finds the first population-based study to use ...

The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

Scientists at Northwestern University have identified a previously hidden toxic protein that may trigger Alzheimer’s disease ...

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from ...

Northwestern University scientists are developing an experimental drug that could serve as an early intervention for Alzheimer’s disease.

In the weeks leading up to Dec. 3, I imagined a fantastic headline: “Ozempic treats Alzheimer’s disease.” ...